What Are Wall Street’s Thoughts On Monte Rosa Therapeutics Inc. Shares (GLUE)?
The stock of Monte Rosa Therapeutics Inc. (NASDAQ:GLUE) increased by $0.01 on Friday to finish at $6.69, up 0.15 percent. The last five days have seen an average of 185,900 shares of common stock traded. 3 times new highs were reached in the current year, with a fall of -$0.92. The average number of shares […]